Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Arzneimittelwerk describes new anticonvulsants

April 24, 1997

Grape seed proanthocyanidins compared to other antioxidants in vitro and in vivo

April 24, 1997

Canadian clearance for Naropin

April 23, 1997

Positive clinical results for mitoxantrone in multiple sclerosis

April 23, 1997

Piracetam as an adjuvant to language therapy for aphasia

April 23, 1997

Novel 5-HT uptake inhibitors from Bristol-Myers Squibb

April 23, 1997

AutoImmune freezes development of Myloral

April 22, 1997

BASF selects dual D4/5-HT2 antagonist for clinical development

April 22, 1997

MS&D designs potent and selective dopamine D4 antagonist

April 21, 1997

New opioid analgesic from Glaxo Wellcome

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...